Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

IMIDomics

IMIDomics is a treatments for immune-mediated inflammatory diseases; Biobank platform.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
Industry
Biology
Biology
Biotechnology
Biotechnology
Drug discovery
Drug discovery
Technology
Technology
Invested in
Pritzker Group Venture Capital
Pritzker Group Venture Capital
DNS Capital
DNS Capital
Bristol-Myers Squibb
Bristol-Myers Squibb
Tao Capital Partners
Tao Capital Partners
Investors
DNS Capital
DNS Capital
Bristol-Myers Squibb
Bristol-Myers Squibb
Latest Funding Round Date
July 27, 2021
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/imidomics-inc
Location
San Francisco
San Francisco
Total Funding Amount (USD)
16,500,000
Official Website
imidomics.com

Find more companies like IMIDomics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.